How about a $477M biotech IPO amid Hong Kong protests? Hen­lius will find out

A third month of protests in Hong Kong is not stop­ping Shang­hai Hen­lius Biotech’s push to get list­ed on its stock ex­change.

The $477 mil­lion IPO bid marks the first big test for HKEX’s nascent biotech cor­ner since the city be­came en­gulfed in po­lit­i­cal tur­moil over a now with­drawn ex­tra­di­tion bill and sub­se­quent po­lice bru­tal­i­ty. Bloomberg has pre­vi­ous­ly re­port­ed that the com­pa­ny was eye­ing as much as $600 mil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.